Home Categories API Ciprofloxacin
A2476312

Ciprofloxacin , ≥98% , 85721-33-1

Synonym(s):
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid;Ciprobay

CAS NO.:85721-33-1

Empirical Formula: C17H18FN3O3

Molecular Weight: 331.34

MDL number: MFCD00185755

EINECS: 617-751-0

Pack Size Price Stock Quantity
1g RMB25.60 In Stock
5G RMB48.80 In Stock
25G RMB128.00 In Stock
100G RMB416.80 In Stock
500g RMB1679.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 255-257°C
Boiling point: 581.8±50.0 °C(Predicted)
Density  1.461±0.06 g/cm3(Predicted)
storage temp.  Keep in dark place,Inert atmosphere,2-8°C
solubility  Soluble in 0.1N HCl at 25mg/ml. Poorly soluble in DMSO
pka pKa 4.04 (Uncertain)
form  powder
color  White to Almost white
Water Solubility  86mg/L(25 ºC)
Merck  14,2314
BRN  3568352

Description and Uses

Ciprofloxacin is a quinolone antibacterial related to recently marketed norfloxacin (10), ofloxacin (2), pefloxacin (2) and enoxacin. It has a broad spectrum of activity against gram-positive and gram-negative bacteria, and is useful in the treatment of urinary and upper respiratory tract infections.

Ciprofloxacin is used in the treatment of infections from a wide range of aerobic gram-positive and aerobic gramnegative microorganisms. It has been shown to be effective against inhalational anthrax and reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis. It is also used in select respiratory infections, urinary tract infections, typhoid fever, some sexually transmitted diseases, and septicemia. Infectious diarrhea may be caused by organisms found in food or water and transferred by person-to-person contact. This may have a devastating effect, globally, especially in immunocompromised individuals. Ciprofloxacin is effective against those organisms that may contribute to infectious diarrhea, such as Escherichia coli (enterotoxigenic strains), Campylobacter jejuni, and select strains of Shigella; and is utilized when antibacterial therapy is medically indicated. Ciprofloxacin has also been utilized as a secondary agent in the treatment of tuberculosis.

Safety

Hazard statements  H412
Precautionary statements  P273-P501
Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-36-24/25
RIDADR  UN 3077 9 / PGIII
WGK Germany  2
RTECS  VB1993800
HS Code  29339900

RELATED PRODUCTS